Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Geode Capital Management
Boston,
Massachusetts
| $849M | +$59.7M | 67 | 0.18% | Increased |
|
| 27 |
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
| $844M | -$54.2M | 1 | 14.91% | Reduced |
|
| 28 |
Fisher Asset Management
Camas,
Washington
| $834M | +$20.8M | 4 | 0.81% | Increased |
|
| 29 |
Charles Schwab
San Francisco,
California
| $829M | +$11.2M | 47 | 0.41% | Increased |
|
| 30 |
RTW Investments
New York
| $826M | -$11.8M | 8 | 23.25% | Reduced |
|
| 31 |
ARK Investment Management
St. Petersburg,
Florida
| $811M | +$184M | 7 | 8.72% | Increased |
|
| 32 |
Bank of New York Mellon
New York
| $756M | +$71.5M | 52 | 0.2% | Increased |
|
| 33 |
Avoro Capital Advisors
New York
| $749M | +$49.6M | 8 | 14.8% | Increased |
|
| 34 |
Invesco
Atlanta,
Georgia
| $736M | -$67.5M | 25 | 0.26% | Reduced |
|
| 35 |
Mawer Investment Management
Calgary,
Alberta, Canada
| $694M | +$19.3M | 1 | 5.11% | Increased |
|
| 36 |
UBS Group
Zurich,
Switzerland
| $679M | -$116M | 71 | 0.29% | Reduced |
|
| 37 |
OrbiMed
New York
| $651M | -$97.2M | 14 | 9.16% | Reduced |
|
| 38 |
Dimensional Fund Advisors
Austin,
Texas
| $621M | +$10.8M | 31 | 0.27% | Increased |
|
| 39 |
Perceptive Advisors
New York
| $619M | +$11.2M | 10 | 10.02% | Increased |
|
| 40 |
Boston Partners
Boston,
Massachusetts
| $581M | +$290M | 1 | 1.07% | Increased |
|
| 41 |
Ameriprise
Minneapolis,
Minnesota
| $576M | -$40.1M | 27 | 0.25% | Reduced |
|
| 42 |
Aristotle Capital Management
Los Angeles,
California
| $574M | +$59.2M | 1 | 1.93% | Increased |
|
| 43 |
Norges Bank
Oslo,
Norway
| $560M | +$22.2M | 22 | 0.16% | Increased |
|
| 44 |
RA Capital Management
Boston,
Massachusetts
| $519M | +$154M | 8 | 10.11% | Increased |
|
| 45 |
CC
Casdin Capital
New York
| $494M | +$89.6M | 12 | 29.21% | Increased |
|
| 46 |
Morgan Stanley
New York
| $478M | -$163M | 70 | 0.11% | Reduced |
|
| 47 |
Artisan Partners
Milwaukee,
Wisconsin
| $473M | +$67.6M | 5 | 0.76% | Increased |
|
| 48 |
AllianceBernstein
Nashville,
Tennessee
| $463M | +$43.9M | 41 | 0.27% | Increased |
|
| 49 |
VVM
Versant Venture Management
San Francisco,
California
| $462M | +$4.73M | 3 | 66.44% | Increased |
|
| 50 |
Millennium Management
New York
| $458M | +$119M | 51 | 0.63% | Increased |
|